SCHEMBL21023295

SCHEMBL21023295

CSc1cc(SC)cc(-c2cccc3c(=O)c4cc5c(cc4n(C)c23)c(=O)c2cccc(-c3cc(SC)cc(SC)c3)c2n5C)c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ATM Q13315 2/20 0.35
▸ L3MBTL1 Q9Y468 3/20 0.34
▸ BRD1 O95696 3/20 0.34
▸ TAF1 P21675 2/20 0.34
▸ BRPF1 P55201 2/20 0.34
▸ KDM4E B2RXH2 3/20 0.33
▸ ALDH1A1 P00352 3/20 0.33
▸ HPGD P15428 3/20 0.33
▸ HSD17B10 Q99714 2/20 0.33
▸ GLA P06280 1/20 0.33
▸ GAA P10253 1/20 0.33
▸ CASP1 P29466 1/20 0.33
▸ HTT P42858 1/20 0.33
▸ CASP7 P55210 1/20 0.33
▸ MAOB P27338 2/20 0.32
▸ HCRTR1 O43613 1/20 0.32
▸ NPC1 O15118 1/20 0.32
▸ RAB9A P51151 1/20 0.32
▸ MAOA P21397 1/20 0.32
▸ NTRK1 P04629 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21023175 0.81 HSD17B10 (0.50) ATML3MBTL1KDM4EHPGDHSD17B10
SCHEMBL21023340 0.78 BRD1 (0.41) ATMBRD1TAF1BRPF1KDM4E
SCHEMBL21023320 0.77 HSD17B10 (0.52) ATML3MBTL1HPGDHSD17B10GAA
SCHEMBL21023300 0.76 L3MBTL1 (0.36) ATML3MBTL1BRD1TAF1BRPF1
SCHEMBL21023337 0.76 GSTP1 (0.45) ATML3MBTL1HSD17B10GAACASP1
SCHEMBL21023294 0.75 PRKDC (0.41) L3MBTL1BRD1TAF1BRPF1MAOB
SCHEMBL21023474 0.75 KIF11 (0.43) ATML3MBTL1MAOBBACE1
SCHEMBL21023179 0.74 BRD4 (0.46) ATMBRD1TAF1BRPF1KDM4E
SCHEMBL21023288 0.74 MAOA (0.42) ATML3MBTL1BRD1TAF1BRPF1
SCHEMBL21023341 0.73 ATM (0.47) ATML3MBTL1BRD1TAF1BRPF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190157350-A1 PHOTOELECTRIC CONVERSION ELEMENT, IMAGING ELEMENT, OPTICAL SENSOR, AND COMPOUND FUJIFILM CORPORATION (JP) 2019-05-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190157350-A1 PHOTOELECTRIC CONVERSION ELEMENT, IMAGING ELEMENT, OPTICAL SENSOR, AND COMPOUND CRY1, CDH1, TEAD1 ATM 2642/4885L3MBTL1 4094/4885BRD1 2921/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback